iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$14.71 USD
-0.27 (-1.77%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $14.69 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Earnings News For ITOS
-
ITeos Therapeutics, Inc. (ITOS) Reports Q2 Loss, Tops Revenue Estimates
-
iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates
-
iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
-
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
iTeos Reports Second Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Reports Q1 Loss, Misses Revenue Estimates
-
iTeos Reports First Quarter 2023 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Q4 Earnings and Revenues Surpass Estimates
-
iTeos Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates
-
iTeos Reports Third Quarter 2022 Financial Results and Provides Business Updates
-
ITeos Therapeutics, Inc. (ITOS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
-
ITeos Therapeutics, Inc. (ITOS) Q2 Earnings and Revenues Lag Estimates
-
ITeos Therapeutics, Inc. (ITOS) Surpasses Q1 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Tops Q4 Earnings and Revenue Estimates
-
ITeos Therapeutics, Inc. (ITOS) Lags Q3 Earnings and Revenue Estimates